A polycystin-1 multiprotein complex is disrupted in polycystic kidney disease cells

被引:115
作者
Roitbak, T
Ward, CJ
Harris, PC
Bacallao, R
Ness, SA
Wandinger-Ness, A [1 ]
机构
[1] Univ New Mexico, Hlth Sci Ctr, Dept Pathol, Albuquerque, NM 87131 USA
[2] Univ New Mexico, Hlth Sci Ctr, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA
[3] Indiana Univ, Med Ctr, Dept Med, Indianapolis, IN 46202 USA
[4] Mayo Clin, Div Nephrol, Rochester, MN 55905 USA
关键词
D O I
10.1091/mbc.E03-05-0296
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Autosomal dominant polycystic kidney disease (ADPKD) is typified by the accumulation of fluid-filled cysts and abnormalities in renal epithelial cell function. The disease is principally caused by mutations in the gene encoding polycystin-1, a large basolateral plasma membrane protein expressed in kidney epithelial cells. Our studies reveal that, in normal kidney cells, polycystin-1 forms a complex with the adherens junction protein E-cadherin and its associated catenins, suggesting a role in cell adhesion or polarity. In primary cells from ADPKD patients, the polycystin-1/polycystin-2/E-cadherin/beta-catenin complex was disrupted and both polycystin-1 and E-cadherin were depleted from the plasma membrane as a result of the increased phosphorylation of polycystin-1. The loss of E-cadherin was compensated by the transcriptional upregulation of the normally mesenchymal N-cadherin. Increased cell surface N-cadherin in the disease cells in turn stabilized the continued plasma membrane localization of beta-catenin in the absence of E-cadherin. The results suggest that enhanced phosphorylation of polycystin-1 in ADPKD cells precipitates changes in its localization and its ability to form protein complexes that are critical for the stabilization of adherens junctions and the maintenance of a fully differentiated polarized renal epithelium.
引用
收藏
页码:1334 / 1346
页数:13
相关论文
共 61 条
[41]   A kinase-regulated mechanism controls CFTR channel gating by disrupting bivalent PDZ domain interactions [J].
Raghuram, V ;
Hormuth, H ;
Foskett, JK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (16) :9620-9625
[42]   The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease [J].
Rossetti, S ;
Burton, S ;
Strmecki, L ;
Pond, GR ;
San Millán, JL ;
Zerres, K ;
Barratt, TM ;
Ozen, S ;
Torres, VE ;
Bergstralh, EJ ;
Winearls, CG ;
Harris, PC .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (05) :1230-1237
[43]   Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the β-catenin gene [J].
Saadi-Kheddouci, S ;
Berrebi, D ;
Romagnolo, B ;
Cluzeaud, F ;
Peuchmaur, M ;
Kahn, A ;
Vandewalle, A ;
Perret, C .
ONCOGENE, 2001, 20 (42) :5972-5981
[44]   Cadherin sequences that inhibit β-catenin signaling:: A study in yeast and mammalian cells [J].
Simcha, I ;
Kirkpatrick, C ;
Sadot, E ;
Shtutman, M ;
Polevoy, G ;
Geiger, B ;
Peifer, M ;
Ben-Ze'ev, A .
MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (04) :1177-1188
[45]  
St Amand AL, 2001, INT REV CYTOL, V203, P291
[46]   E-cadherin regulates cell growth by modulating proliferation-dependent β-catenin transcriptional activity [J].
Stockinger, A ;
Eger, A ;
Wolf, J ;
Beug, H ;
Foisner, R .
JOURNAL OF CELL BIOLOGY, 2001, 154 (06) :1185-1196
[47]   Polycystin-1 transforms the cAMP growth-responsive phenotype of M-1 cells [J].
Sutters, M ;
Yamaguchi, T ;
Maser, RL ;
Magenheimer, BS ;
St John, PL ;
Abrahamson, DR ;
Grantham, JJ ;
Calvet, JP .
KIDNEY INTERNATIONAL, 2001, 60 (02) :484-494
[48]  
Taddei ML, 2002, CANCER RES, V62, P6489
[49]  
Tomita K, 2000, CANCER RES, V60, P3650
[50]   Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2 [J].
Tsiokas, L ;
Kim, E ;
Arnould, T ;
Sukhatme, VP ;
Walz, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (13) :6965-6970